NDSIB
RVMD icon

North Dakota State Investment Board’s Revolution Medicines RVMD Stock Holding History

North Dakota State Investment Board’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$999K Buy
5,334
+267
+5% +$39K 0.04% 336
2026
Q1 		$493K Sell
5,067
-1,025
-17% -$104K 0.02% 472
2025
Q4 		$485K Buy
+6,092
New +$399K 0.02% 531

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

North Dakota State Investment Board's RVMD Position: Q2 2026 in Review

North Dakota State Investment Board increased its Revolution Medicines (RVMD) stake by 5.3% in Q2 2026, buying an estimated $39K and bringing the position to 5,334 shares worth $999K. The position accounts for 0.04% of the portfolio, ranked #336.

North Dakota State Investment Board first reported a position in RVMD in Q4 2025 and has held it in 3 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • North Dakota State Investment Board held 5,334 shares of Revolution Medicines worth $999K as of Q2 2026.
  • North Dakota State Investment Board bought 267 Revolution Medicines shares in Q2 2026, an estimated $39K.
  • Revolution Medicines made up 0.04% of North Dakota State Investment Board's portfolio in Q2 2026, its #336 holding.
  • North Dakota State Investment Board first reported a position in Revolution Medicines in Q4 2025 and has held it in 3 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.